Darmstadt, Germany

Tanja Reuter



Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Celebrating the Innovations of Inventor Tanja Reuter

Introduction: Tanja Reuter is a distinguished inventor based in Darmstadt, Germany, renowned for her contributions to the pharmaceutical industry. With a focus on developing innovative compounds that target specific kinase activities, she has secured a total of three patents that highlight her expertise and commitment to advancing medical science.

Latest Patents: Tanja Reuter's latest patents reflect her dedication to creating effective pharmaceutical compositions. One of her notable inventions is the patent for "Pyrrolopyrimidines for pharmaceutical compositions." This invention introduces novel pyrrolopyrimidine compounds designed for the prophylaxis and treatment of diseases influenced by the inhibition of Mnk1 and/or Mnk2 kinase activity. Another significant patent is for "Thienopyrimidines having Mnk1/Mnk2 inhibiting activity for pharmaceutical compositions," which also aims to offer new therapeutic solutions by utilizing thienopyrimidine compounds.

Career Highlights: In her professional journey, Tanja Reuter has made substantial contributions while working at Boehringer Ingelheim International GmbH. Her work centers on innovative drug development, showcasing her ability to navigate the complexities of pharmaceutical research and drive advancements in treatment options.

Collaborations: Tanja has collaborated with notable colleagues, including Stephen Murfin and Thomas Stephen Coulter. These partnerships emphasize her collaborative spirit and her role within a team of talented professionals dedicated to pushing the boundaries of drug development.

Conclusion: Tanja Reuter stands out as an innovative inventor whose patents pave the way for future pharmaceutical advancements. Her work in the realm of pyrrolopyrimidine and thienopyrimidine compounds showcases her commitment to addressing unmet medical needs. With the support of her colleagues and her position at Boehringer Ingelheim International GmbH, she continues to contribute significantly to the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…